- Morningstar•24 days ago
The market overestimates the sustainability of recent commodity rallies, leaving the basic materials sector severely overvalued.
- Capital Cube•2 months ago
Click here to see latest analysisSynthetic Biologics, Inc. reports financial results for the quarter ended March 31, 2016.AnalysisSummary numbers: Revenues of USD 0 million, Net Earnings of USD -10.85 million.The company did not record any revenues for the last twelve months making the comparison of net margin versus asset turnover meaningless.SYN-US‘s earnings and EBITDA are […] (Read more...) The post Synthetic Biologics, Inc. :SYN-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016 appeared first on CapitalCube.
Synthetic Biologics Inc.NYSE MKT
After hours: 1.700.00 (0.00%) as of 4:44 PM EDT
|Bid||1.60 x 10600|
|Ask||1.73 x 1400|
|52wk Range||0.93 - 3.45|
|Day's Range||1.66 - 1.73|
|Avg Vol (3m)||702,904|
As of 4:02 PM EDT. Market closed.